fda glp-1 compounding warning september 2025 Issues 30 Letters to Telehealth Firms Over Misleading Compounded Marketing FDA Demurs on GLP-1 Compounding

doi: 10.1002/jcp.26280 [DOI] [PubMed] [Google Scholar] 53

Eligibility depends on the medication and the patients health history

Why it matters: Large meals sit uncomfortably in your slowed stomach, triggering nausea, reflux, and bloating

Some patients who experienced libido changes on semaglutide report improvement after switching to tirzepatide, though this is anecdotal rather than evidence-based

However, many others are considered experimental or are prescribed off-label, meaning their use for certain conditions has not yet been approved by the FDA

Int J Cancer 97(6):740745 Kroning R, Lichtenstein AK, Nagami GT (2000) Sulfur-containing amino acids decrease cisplatin cytotoxicity and uptake in renal tubule epithelial cell lines